---
title: "CrystalGenomics and Standigm, Agree to Collaborate on Utilizing Artificial Intelligence and Structure-Based Drug Design Technologies in Drug R&D"
date: June 1, 2017
categories:
  - Press
---

Seoul, Korea, South, June 01, 2017 –(PR.com)– CrystalGenomics, Inc. (KOSDAQ: 083790) and Standigm, Inc., today announced the collaborative partnership to apply Artificial Intelligence (AI) to the research and development of novel drugs.


[Read more](http://www.prnewswire.com/news-releases/deep-learning-in-drug-discovery-and-diagnostics-2017---2035-300490428.html)

